A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...

A new study from Mass Eye and Ear suggests that people taking semaglutide, a drug sold as Ozempic and Wegovy, may have a ...

A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...

A small percentage have had vision problems, but a direct causal link with the drugs has not been established.

Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...

Popular GLP-1 medications like semaglutide and tirzepatide have been linked to rare vision issues, including NAION, raising ...

Following the onset of nonarteritic anterior ischemic optic neuropathy, regular stroke workup may be necessary.

The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...

Physician–scientists at the University of Utah's John A. Moran Eye Center have published an investigatory review of nine ...

Get Instant Summarized Text (Gist) Once-weekly semaglutide use in individuals with type 2 diabetes more than doubles the risk of developing nonarteritic anterior ischemic optic neuropathy (NAION ...

Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy in those with type 2 diabetes.

Semaglutide exposure was significantly associated with a higher incidence rate and independently predicted a higher risk for upcoming nonarteritic anterior ischemic optic neuropathy. HealthDay ...